Ir directamente a la navegación principal
Ir directamente a la búsqueda
Ir directamente al contenido principal
Scholars @ UT Health San Antonio Inicio
Ayuda y preguntas frecuentes
English
Español
Inicio
Perfiles
Unidades de investigación
Producción científica
Conjuntos de datos
Buscar por experiencia, nombre o afiliación
Practice guidelines for diseases caused by Aspergillus
David A. Stevens
, Virginia L. Kan
, Marc A. Judson
, Vicki A. Morrison
, Stephen Dummer
, David W. Denning
, John E. Bennett
, Thomas J. Walsh
,
Thomas F. Patterson
, George A. Pankey
Division of Infectious Diseases
Producción científica
:
Review article
›
revisión exhaustiva
770
Citas (Scopus)
Información general
Huella
Huella
Profundice en los temas de investigación de 'Practice guidelines for diseases caused by Aspergillus'. En conjunto forman una huella única.
Clasificar por
Ponderación
Alfabéticamente
Medicine and Dentistry
Combination Therapy
100%
Patient
100%
Diseases
71%
Corticosteroid
71%
Aspergilloma
71%
Itraconazole
57%
Hemoptysis
57%
Life
57%
Serum
42%
Amphotericin
42%
Therapeutic Procedure
42%
Morbidity
28%
Surgery
28%
Invasive Aspergillosis
28%
Aspergillus
28%
Immunocompromised Patient
28%
Allergic Bronchopulmonary Aspergillosis
28%
Drug
28%
Chemotherapeutic Agent
28%
Disease Predisposition
14%
Thorax Radiography
14%
Drug Therapy
14%
Antifungal Agent
14%
Diagnosis
14%
Aspergillosis
14%
Silo-Filler's Disease
14%
Lipid
14%
Immunoglobulin E
14%
Intravenous Drug Administration
14%
Kidney Function
14%
Lung Injury
14%
Treatment Duration
14%
Personal Experience
14%
Creatinine
14%
Infection
14%
Spirometry
14%
Health Care Cost
14%
Prednisone
14%
Amphotericin B Deoxycholate
14%
Disease Course
14%
Immunotherapy
14%
Nephrotoxicity
14%
Organ Systems
14%
Paracetamol
14%
Deoxycholic Acid
14%
Sarcoidosis
14%
Symptom
14%
Combination Chemotherapy
14%
Corticosteroid Therapy
14%
Mortality
14%
Arterial Embolization
14%
Bronchial Artery
14%
Reading
14%
Base
14%
Student
14%
Experience
14%
Clotiazepam
14%
Inpatient
14%
Consensus
14%
Adjuvant Therapy
14%
Monitoring
14%
Lung Function
14%
Pharmacology, Toxicology and Pharmaceutical Science
Diseases
71%
Corticosteroid
71%
Aspergilloma
71%
Itraconazole
57%
Hemoptysis
57%
Amphotericin
42%
Invasive Aspergillosis
28%
Aspergillus
28%
Immunocompromised Patient
28%
Morbidity
28%
Allergic Bronchopulmonary Aspergillosis
28%
Drug
28%
Maximum Tolerated Dose
14%
Aspergillosis
14%
Intravenous Therapy
14%
Lung Disease
14%
Lipid
14%
Amphotericin B Deoxycholate
14%
Infection
14%
Antifungal Agent
14%
Nephrotoxicity
14%
Immunotherapy
14%
Prednisone
14%
Paracetamol
14%
Creatinine
14%
Lung Injury
14%
Disease Predisposition
14%
Immunoglobulin E
14%
Deoxycholic Acid
14%
Sarcoidosis
14%
Disease Course
14%
Mortality
14%
Base
14%
Clotiazepam
14%
Symptom
14%